Information Journal Paper
APA:
CopySHI, Y.. (2015). A COMBINATION OF THE TELOMERASE INHIBITOR, BIBR1532, AND PACLITAXEL SYNERGISTICALLY INHIBIT CELL PROLIFERATION IN BREAST CANCER CELL LINES. TARGET ONCOL, 10(4), 565-573. SID. https://sid.ir/paper/707038/en
Vancouver:
CopySHI Y.. A COMBINATION OF THE TELOMERASE INHIBITOR, BIBR1532, AND PACLITAXEL SYNERGISTICALLY INHIBIT CELL PROLIFERATION IN BREAST CANCER CELL LINES. TARGET ONCOL[Internet]. 2015;10(4):565-573. Available from: https://sid.ir/paper/707038/en
IEEE:
CopyY. SHI, “A COMBINATION OF THE TELOMERASE INHIBITOR, BIBR1532, AND PACLITAXEL SYNERGISTICALLY INHIBIT CELL PROLIFERATION IN BREAST CANCER CELL LINES,” TARGET ONCOL, vol. 10, no. 4, pp. 565–573, 2015, [Online]. Available: https://sid.ir/paper/707038/en